SCHEMBL17067733

SCHEMBL17067733

Cc1ccc(S(=O)(=O)Nc2cccc3ccc4cccnc4c23)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 8/20 0.81
▸ SLC40A1 Q9NP59 8/20 0.81
▸ KMT2A Q03164 7/20 0.81
▸ AGTR1 P30556 3/20 0.81
▸ LMNA P02545 2/20 0.81
▸ MAPT P10636 2/20 0.81
▸ NPSR1 Q6W5P4 2/20 0.81
▸ MITF O75030 1/20 0.81
▸ S1PR4 O95977 1/20 0.81
▸ ALDH1A1 P00352 1/20 0.81
▸ S1PR1 P21453 1/20 0.81
▸ OPRK1 P41145 1/20 0.81
▸ HTT P42858 1/20 0.81
▸ CKS1B P61024 1/20 0.81
▸ SKP2 Q13309 1/20 0.81
▸ MEN1 O00255 6/20 0.64
▸ GLO1 Q04760 6/20 0.61
▸ NFKBIA P25963 2/20 0.61
▸ G6PD P11413 1/20 0.61
▸ METAP2 P50579 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4471796 0.89 TDP1 (1.00) TDP1SLC40A1KMT2AAGTR1LMNA
SCHEMBL2337402 0.88 TDP1 (0.97) TDP1SLC40A1KMT2AAGTR1LMNA
SCHEMBL5572103 0.88 TDP1 (0.97) TDP1SLC40A1KMT2AAGTR1LMNA
SCHEMBL15299831 0.88 TDP1 (0.97) TDP1SLC40A1KMT2AAGTR1LMNA
SCHEMBL10993205 0.83 LMNA (0.65) TDP1SLC40A1KMT2AAGTR1LMNA
SCHEMBL30553440 0.82 SLC40A1 (0.85) TDP1SLC40A1KMT2AAGTR1LMNA
SCHEMBL6688368 0.82 SLC40A1 (0.85) TDP1SLC40A1KMT2AAGTR1LMNA
SCHEMBL26053588 0.79 KMT2A (1.00) TDP1SLC40A1KMT2AAGTR1LMNA
SCHEMBL13485950 0.79 SLC40A1 (0.80) TDP1SLC40A1KMT2AAGTR1LMNA
SCHEMBL30925445 0.77 SLC40A1 (0.82) TDP1SLC40A1KMT2AAGTR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9926618-B2 Extracting agent for separating lithium isotopes and use thereof SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2018-03-27 — — US disclosed
US-9926618-B2 Extracting agent for separating lithium isotopes and use thereof SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2018-03-27 — — US disclosed
US-20150299822-A1 EXTRACTING AGENT FOR SEPARATING LITHIUM ISOTOPES AND USE THEREOF SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2015-10-22 — — US disclosed
US-20150299822-A1 EXTRACTING AGENT FOR SEPARATING LITHIUM ISOTOPES AND USE THEREOF SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2015-10-22 — — US disclosed
EP-2915576-A1 EXTRACTING AGENT FOR SEPARATING LITHIUM ISOTOPES AND USE THEREOF Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (CN) 2015-09-09 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150299822-A1 EXTRACTING AGENT FOR SEPARATING LITHIUM ISOTOPES AND USE THEREOF TCF7L2, LUC7L2, CDK7 TDP1 3930/4885SLC40A1 1981/4885KMT2A 641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback